These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Glucose modulates the amount, but not the kinetics, of insulin released by sulfonylureas. Gregorio F; Ambrosi F; Filipponi P; Cristallini S; Santeusanio F J Diabetes Complications; 1994; 8(4):204-12. PubMed ID: 7833495 [TBL] [Abstract][Full Text] [Related]
23. Effect of tolbutamide, glyburide and glipizide administered supraspinally on CA3 hippocampal neuronal cell death and hyperglycemia induced by kainic acid in mice. Kim CH; Park SH; Sim YB; Kim SS; Kim SJ; Lim SM; Jung JS; Suh HW Brain Res; 2014 May; 1564():33-40. PubMed ID: 24713348 [TBL] [Abstract][Full Text] [Related]
24. Changes in plasma amino acids levels and "in vivo" gluconeogenesis from alanine in rats chronically treated with sulfonylureas. Alemany M; Palou A; Codina J; Herrera E Diabete Metab; 1978 Sep; 4(3):181-6. PubMed ID: 101403 [No Abstract] [Full Text] [Related]
25. [Insulin and pro-insulin secretion following intravenous administration of tolbutamide, glisoxepide and glibenclamide]. Hausmann L; Schumann G; Kaffarnik H Arzneimittelforschung; 1978; 28(1):83-6. PubMed ID: 415745 [TBL] [Abstract][Full Text] [Related]
26. Effects of glimepiride and glyburide on glucose counterregulation and recovery from hypoglycemia. Szoke E; Gosmanov NR; Sinkin JC; Nihalani A; Fender AB; Cryer PE; Meyer C; Gerich JE Metabolism; 2006 Jan; 55(1):78-83. PubMed ID: 16324923 [TBL] [Abstract][Full Text] [Related]
27. Gliflumide, a new oral antidiabetic of high potency and efficacy. Blumenbach L; Gerhards E; Gutsche H; Klein W; Loge O; Losert W; Schillinger E; Speck U; Vetter H; Wendt H Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):141-51. PubMed ID: 809367 [TBL] [Abstract][Full Text] [Related]
28. [Experimental study of glipizide. A comparison with other hypoglycemic sulfonamides (author's transl)]. Loubatières AL; Loubatieres-Mariani MM; Alric R; Ribes G; Sorial G; Tarasco A Diabete Metab; 1975 Mar; 1():13-21. PubMed ID: 824163 [TBL] [Abstract][Full Text] [Related]
29. [Pharmacologic study with glisoxepide and other blood sugar reducing sulfonamide derivatives in metabolically healthy subjects and diabetics]. Haupt E; Beyer J; Schöffling K Arzneimittelforschung; 1974 Mar; 24(0):418-25. PubMed ID: 4211557 [No Abstract] [Full Text] [Related]
30. Insulin exocytosis in Goto-Kakizaki rat beta-cells subjected to long-term glinide or sulfonylurea treatment. Kawai J; Ohara-Imaizumi M; Nakamichi Y; Okamura T; Akimoto Y; Matsushima S; Aoyagi K; Kawakami H; Watanabe T; Watada H; Kawamori R; Nagamatsu S Biochem J; 2008 May; 412(1):93-101. PubMed ID: 18254725 [TBL] [Abstract][Full Text] [Related]
31. The effect of oral sulphonylureas on blood glucose and insulin. Adadevoh BK; Bolodeoku JO Ghana Med J; 1973 Dec; 12(4):360-5. PubMed ID: 4282692 [No Abstract] [Full Text] [Related]
33. [Comparative studies between HB 419 (glibenclamide) and tolbutamide on their effect on insulin liberation in isolated islands of rat pancreas in vitro]. Weinges KF; Biro G; Kettl H; Mitzuno M Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1467-9. PubMed ID: 4899089 [No Abstract] [Full Text] [Related]
34. Cardiovascular effects of conventional sulfonylureas and glimepiride. Geisen K; Végh A; Krause E; Papp JG Horm Metab Res; 1996 Sep; 28(9):496-507. PubMed ID: 8911987 [TBL] [Abstract][Full Text] [Related]
35. [Comparative use of gliquidone and tolbutamide administered intravenously]. Zilker T; Lüders L; Bottermann P MMW Munch Med Wochenschr; 1975 Sep; 117(36):1421-2. PubMed ID: 126376 [No Abstract] [Full Text] [Related]
36. [The influence of various sulphonylurea derivatives on the oral glucose-tolerance tests in healthy subjects and obese and maturity-onset diabetics (author's transl)]. Haupt E; Beyer J; Schöffling K Dtsch Med Wochenschr; 1974 Mar; 99(9):385-8. PubMed ID: 4208186 [No Abstract] [Full Text] [Related]
37. [Effect of glycemia level on insulin secretion caused by an hypoglycemic sulfamide (glisoxepide) in dogs]. Loubatières AL; Ribes G; Loubatières-Mariani MM C R Seances Soc Biol Fil; 1972; 166(8):1047-50. PubMed ID: 4573746 [No Abstract] [Full Text] [Related]
38. A comparison of the effects of tolazamide and tolbutamide upon blood glucose and serum insulin and lipid levels in diabetic subjects. Moorhouse JA Can Med Assoc J; 1967 Mar; 96(9):536-9. PubMed ID: 6019354 [TBL] [Abstract][Full Text] [Related]
39. The pharmacology of a new hypoglycaemic agent N-[4-(2-(2,3-dihydrobenzo(b)furan-m-carboxamido)-ethyl)-benzenesulphonyl]-N'-cyclohexylurea (NOVO CS 476). I. Pharmacological studies on the hypoglycaemic effect. Jorgensen KD Acta Pharmacol Toxicol (Copenh); 1977 Feb; 40(2):216-26. PubMed ID: 402791 [TBL] [Abstract][Full Text] [Related]
40. Hypoglycemic and hypotriglyceridemic effects of tolbutamide in triphenyltin chloride-induced diabetic rabbits. Watanabe M; Watanabe K; Matsui H Vet Hum Toxicol; 2002 Jun; 44(3):140-4. PubMed ID: 12046964 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]